These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 25569630)

  • 21. The serine protease inhibitor Ecotin is required for full virulence of Burkholderia pseudomallei.
    Ireland PM; Marshall L; Norville I; Sarkar-Tyson M
    Microb Pathog; 2014; 67-68():55-8. PubMed ID: 24462575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Global map of growth-regulated gene expression in Burkholderia pseudomallei, the causative agent of melioidosis.
    Rodrigues F; Sarkar-Tyson M; Harding SV; Sim SH; Chua HH; Lin CH; Han X; Karuturi RK; Sung K; Yu K; Chen W; Atkins TP; Titball RW; Tan P
    J Bacteriol; 2006 Dec; 188(23):8178-88. PubMed ID: 16997946
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of BPSS1521 (bprD), a regulator of Burkholderia pseudomallei virulence gene expression in the mouse model.
    Chirakul S; Bartpho T; Wongsurawat T; Taweechaisupapong S; Karoonutaisiri N; Talaat AM; Wongratanacheewin S; Ernst RK; Sermswan RW
    PLoS One; 2014; 9(8):e104313. PubMed ID: 25111708
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of signature-tagged mutagenesis in Burkholderia pseudomallei to identify genes important in survival and pathogenesis.
    Cuccui J; Easton A; Chu KK; Bancroft GJ; Oyston PC; Titball RW; Wren BW
    Infect Immun; 2007 Mar; 75(3):1186-95. PubMed ID: 17189432
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Attenuation of a select agent-excluded Burkholderia pseudomallei capsule mutant in hamsters.
    Gutierrez MG; Warawa JM
    Acta Trop; 2016 May; 157():68-72. PubMed ID: 26836271
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The molecular and cellular basis of pathogenesis in melioidosis: how does Burkholderia pseudomallei cause disease?
    Lazar Adler NR; Govan B; Cullinane M; Harper M; Adler B; Boyce JD
    FEMS Microbiol Rev; 2009 Nov; 33(6):1079-99. PubMed ID: 19732156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unraveling type III secretion systems in the highly versatile Burkholderia pseudomallei.
    Sun GW; Gan YH
    Trends Microbiol; 2010 Dec; 18(12):561-8. PubMed ID: 20951592
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An Inv/Mxi-Spa-like type III protein secretion system in Burkholderia pseudomallei modulates intracellular behaviour of the pathogen.
    Stevens MP; Wood MW; Taylor LA; Monaghan P; Hawes P; Jones PW; Wallis TS; Galyov EE
    Mol Microbiol; 2002 Nov; 46(3):649-59. PubMed ID: 12410823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel FK-506-binding-like protein that lacks peptidyl-prolyl isomerase activity is involved in intracellular infection and in vivo virulence of Burkholderia pseudomallei.
    Norville IH; Breitbach K; Eske-Pogodda K; Harmer NJ; Sarkar-Tyson M; Titball RW; Steinmetz I
    Microbiology (Reading); 2011 Sep; 157(Pt 9):2629-2638. PubMed ID: 21680634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genome-wide expression analysis of Burkholderia pseudomallei infection in a hamster model of acute melioidosis.
    Tuanyok A; Tom M; Dunbar J; Woods DE
    Infect Immun; 2006 Oct; 74(10):5465-76. PubMed ID: 16988221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapid DNA vaccination against Burkholderia pseudomallei flagellin by tattoo or intranasal application.
    Lankelma JM; Wagemakers A; Birnie E; Haak BW; Trentelman JJA; Weehuizen TAF; Ersöz J; Roelofs JJTH; Hovius JW; Wiersinga WJ; Bins AD
    Virulence; 2017 Nov; 8(8):1683-1694. PubMed ID: 28323523
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distinct Pathogenic Patterns of
    Chen YL; Hsu DW; Hsueh PT; Chen JA; Shih PJ; Lee S; Lin HH; Chen YS
    Am J Trop Med Hyg; 2019 Oct; 101(4):736-745. PubMed ID: 31392941
    [No Abstract]   [Full Text] [Related]  

  • 33. Virulence from the rhizosphere: ecology and evolution of Burkholderia pseudomallei-complex species.
    French CT; Bulterys PL; Woodward CL; Tatters AO; Ng KR; Miller JF
    Curr Opin Microbiol; 2020 Apr; 54():18-32. PubMed ID: 32028234
    [No Abstract]   [Full Text] [Related]  

  • 34. A Burkholderia pseudomallei deltapurM mutant is avirulent in immunocompetent and immunodeficient animals: candidate strain for exclusion from select-agent lists.
    Propst KL; Mima T; Choi KH; Dow SW; Schweizer HP
    Infect Immun; 2010 Jul; 78(7):3136-43. PubMed ID: 20404077
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A proteasome inhibitor produced by Burkholderia pseudomallei modulates intracellular growth.
    Wagley S; Vanaporn M; Rinchai D; Conejero L; Lertmemongkolchai G; Bancroft GJ; Titball RW
    Microb Pathog; 2017 Jun; 107():175-180. PubMed ID: 28323151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Burkholderia pseudomallei as an Enteric Pathogen: Identification of Virulence Factors Mediating Gastrointestinal Infection.
    Sanchez-Villamil JI; Tapia D; Borlee GI; Borlee BR; Walker DH; Torres AG
    Infect Immun; 2020 Dec; 89(1):. PubMed ID: 33106293
    [No Abstract]   [Full Text] [Related]  

  • 37. BALB/c and C57Bl/6 mice infected with virulent Burkholderia pseudomallei provide contrasting animal models for the acute and chronic forms of human melioidosis.
    Leakey AK; Ulett GC; Hirst RG
    Microb Pathog; 1998 May; 24(5):269-75. PubMed ID: 9600859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inactivation of bpsl1039-1040 ATP-binding cassette transporter reduces intracellular survival in macrophages, biofilm formation and virulence in the murine model of Burkholderia pseudomallei infection.
    Pinweha P; Pumirat P; Cuccui J; Jitprasutwit N; Muangsombut V; Srinon V; Boonyuen U; Thiennimitr P; Vattanaviboon P; Cia F; Willcocks S; Bancroft GJ; Wren BW; Korbsrisate S
    PLoS One; 2018; 13(5):e0196202. PubMed ID: 29771915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polyphosphate kinase 1 of Burkholderia pseudomallei controls quorum sensing, RpoS and host cell invasion.
    Srisanga K; Suthapot P; Permsirivisarn P; Govitrapong P; Tungpradabkul S; Wongtrakoongate P
    J Proteomics; 2019 Mar; 194():14-24. PubMed ID: 30597312
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A predicted cation transporter protein, BPSS1228, is involved in intracellular behaviour of Burkholderia pseudomallei in a human lung epithelial cell line (A549).
    Techawiwattanaboon T; Chareonsudjai S
    FEMS Microbiol Lett; 2016 Dec; 363(23):. PubMed ID: 28003338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.